Cargando…
How should individual participant data (IPD) from publicly funded clinical trials be shared?
BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidanc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682216/ https://www.ncbi.nlm.nih.gov/pubmed/26675031 http://dx.doi.org/10.1186/s12916-015-0532-z |
_version_ | 1782405858504736768 |
---|---|
author | Tudur Smith, C. Hopkins, C. Sydes, M. R. Woolfall, K. Clarke, M. Murray, G. Williamson, P. |
author_facet | Tudur Smith, C. Hopkins, C. Sydes, M. R. Woolfall, K. Clarke, M. Murray, G. Williamson, P. |
author_sort | Tudur Smith, C. |
collection | PubMed |
description | BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidance to facilitate the sharing of IPD from publicly funded clinical trials. METHODS: Development of the guidance was completed over four phases which included a focussed review of policy documents, a web-based survey of the UK Clinical Research Collaboration (CRC) Registered Clinical Trials Units (CTU) Network, participation of an expert committee and an open consultation with the UKCRC Registered CTU Network. The project was funded by the MRC HTMR (MR/L004933/1-R39). RESULTS: Good practice principles include: (i) the use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (ii) seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (iii) establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD. The guidance has been endorsed by Cancer Research UK, MRC Methodology Research Programme Advisory Group, Wellcome Trust and the Executive Group of the UKCRC Registered CTU Network. The National Institute for Health Research (NIHR) has confirmed it is supportive of the application of this guidance. CONCLUSIONS: Implementation of these principles will improve transparency, increase the coherent sharing of IPD from publicly funded trials, and help publicly funded trials to adhere to trial funder and journal requirements for data sharing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-015-0532-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4682216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46822162015-12-18 How should individual participant data (IPD) from publicly funded clinical trials be shared? Tudur Smith, C. Hopkins, C. Sydes, M. R. Woolfall, K. Clarke, M. Murray, G. Williamson, P. BMC Med Guideline BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidance to facilitate the sharing of IPD from publicly funded clinical trials. METHODS: Development of the guidance was completed over four phases which included a focussed review of policy documents, a web-based survey of the UK Clinical Research Collaboration (CRC) Registered Clinical Trials Units (CTU) Network, participation of an expert committee and an open consultation with the UKCRC Registered CTU Network. The project was funded by the MRC HTMR (MR/L004933/1-R39). RESULTS: Good practice principles include: (i) the use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (ii) seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (iii) establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD. The guidance has been endorsed by Cancer Research UK, MRC Methodology Research Programme Advisory Group, Wellcome Trust and the Executive Group of the UKCRC Registered CTU Network. The National Institute for Health Research (NIHR) has confirmed it is supportive of the application of this guidance. CONCLUSIONS: Implementation of these principles will improve transparency, increase the coherent sharing of IPD from publicly funded trials, and help publicly funded trials to adhere to trial funder and journal requirements for data sharing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-015-0532-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-17 /pmc/articles/PMC4682216/ /pubmed/26675031 http://dx.doi.org/10.1186/s12916-015-0532-z Text en © Tudur Smith et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Guideline Tudur Smith, C. Hopkins, C. Sydes, M. R. Woolfall, K. Clarke, M. Murray, G. Williamson, P. How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title | How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title_full | How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title_fullStr | How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title_full_unstemmed | How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title_short | How should individual participant data (IPD) from publicly funded clinical trials be shared? |
title_sort | how should individual participant data (ipd) from publicly funded clinical trials be shared? |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682216/ https://www.ncbi.nlm.nih.gov/pubmed/26675031 http://dx.doi.org/10.1186/s12916-015-0532-z |
work_keys_str_mv | AT tudursmithc howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT hopkinsc howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT sydesmr howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT woolfallk howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT clarkem howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT murrayg howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared AT williamsonp howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared |